The showcased AI 3D Body Management System utilizes non-contact scanning to record body contour changes accurately and, through AI data analysis, provides personalized posture insights and product recommendations.
This technology supports a wide range of applications, including post-mastectomy rehabilitation, postpartum body recovery, and posture correction, helping women better understand their bodies in a scientific, safe, and data-driven way—leading to healthier, more confident choices in supportive and wellness garments.

The 2025 Healthcare+ Expo Taiwan is set to feature a new "Ageless Zone" (無齡專區). ProGuard BioMed Co., Ltd. is officially launching its presence at the expo, adopting the theme: "Comprehensive Protection: Building a New Future of Health." The company will be debuting its products in collaboration with Coarse Taste Lifestyle (粗味生活).
ProGuard BioMed was established by an interdisciplinary team from the NCCU EMBA Biomedical Platform, integrating expertise in nutrition, medicine, and the biotech industry. The company is dedicated to developing functional health supplements that are clinically validated, safe, and effective.
Its brand, ProGuard, uses the "shield" as a symbol of defending health. The product line offers personalized health protection solutions for modern individuals, covering four key areas:
Men's Protection
Sleep & Brain Health
Women's Beauty & Vitality
Joint & Mobility Support
At this year's expo, the combination of ProGuard's offerings and Coarse Taste's "Good Times" aims to ensure that customers "are full of vitality every day."

This groundbreaking technology is the world’s first AI-powered dynamic ultrasound system for shoulder joint analysis. It captures real-time motion of the acromion and greater tuberosity during shoulder activity and uses deep learning to quantify the risk of subacromial impingement syndrome. Unlike traditional static and subjective assessments, this system offers objective, fast, and visualized diagnostic support. Designed for physical medicine and orthopedic use, it integrates with self-paid injection therapies and rehabilitation, delivering dual clinical and commercial value for the management of common shoulder pain conditions.

[b]Genicore leverages its leading Genimer™ Aptamer Screening Technology Platform to offer custom services.[/b] Due to the aptamer's small molecule structure, high affinity, and superior manufacturing stability, this technology effectively overcomes the cost and time limitations associated with traditional antibodies.
[b]At the exhibition, we are launching several innovative tools:
1. His-Tag Protein Capture Kit:[/b]
Utilizes Genimer™ probes to achieve ultra-high specificity capture.
Delivers ultra-high-purity proteins with no metal or chemical residues, making it perfectly suitable for sensitive downstream analyses (such as mass spectrometry).
[b]2. Complete Exosome Solution:
Product 1 - CD63 Exosome Capture Kit:[/b] Ensures the complete structure and functionality of exosomes through gentle elution, achieving a [b]2.5-fold increase in capture efficiency[/b] compared to traditional affinity methods.
[b]Product 2 - CD9 & CD63 Exosome Detection Kit:[/b] Features a sensitivity [b]hundreds of times higher[/b] than competing products, allowing for the precise quantification of exosomes using extremely small sample volumes.
[b]Genimer™ technology is being widely applied across medical diagnostics and regenerative medicine.[/b] Genicore invites the industry to collaborate and forge a new future for biotechnology.

At the 2025 Healthcare Expo Taiwan, Lis Tech will present a portfolio of cutting-edge solutions focusing on 3D cell culture, 3D bioprinting, and exosome purification technologies. Representing Sumitomo Bakelite’s Sbio™ series, the showcase will include PrimeSurface™ 3D cell culture plates and the BioStellar™ organoid culture platform. In addition, Lis Tech will feature the 3D bioprinters from Korea’s ROKIT Healthcare, highlighting the integration of AI with 3D bioprinting in regenerative medicine to advance from 2D culture toward a true in vivo–like environment. Meanwhile, GeniCore Biotech will highlight its Genimer™ platform, offering highly sensitive exosome detection and purification tools to support researchers in exosome studies. Lis Tech is committed to integrating global innovations to accelerate Taiwan’s path toward regenerative and precision medicine.

Biotaitan Molmed Co., Ltd. focused on developing rapid real-time quantitative PCR (rRT-PCR) platform for point-of-care testing (POCT). The platform is designed for molecular precision testing applications in healthcare facilities, ambulances, clinics, pharmacies and homes. At the latest trade show, Biotaitan launched AcesoBox, a portable POCT rRT-PCR device. The device uses a patented rapid thermal cycle system that integrates multi-channel optical detection, allowing users to process samples through simple extraction and obtain up to 15 target results within 5-10 minutes, demonstrating excellent market competitiveness.

The application of medical robots is becoming increasingly widespread, playing a crucial role in daily healthcare tasks. Take the seemingly simple task of urinary care as an example, which has traditionally been performed by healthcare professionals. However, with the onset of an aging society, the loads for medical cares but shortage of healthcare personnel has become an increasingly serious problem. In response to these challenges, research teams have been working continuously through discussions and clinical trials to improve the design of medical robots._x000D_
_x000D_
Our solution not only helps reduce the burden on healthcare workers but also improves the quality of medical services. In the future, we expect more types of medical robots to emerge, making significant contributions to human health and well-being._x000D_

Wine-Font Inc. is leading provider of cutting-edge medical devices, will showcase its latest range of diagnostic solutions at the upcoming Healthcare Expo Taiwan. The company is committed to empowering healthcare professionals with accurate and reliable tools for improved patient care. _x000D_
_x000D_
Key products on display include:_x000D_
* Roche cobas b 101 system: A comprehensive biochemistry analyzer for HbA1c, lipid profile, and CRP testing._x000D_
* Roche cobas h232 cardiac reader: A high-precision cardiac marker analyzer for rapid and accurate results._x000D_
* Urisys® 1100 urine analyzer: A reliable urine analyzer with connectivity to cobas POC IT solution._x000D_
* Radiometer ABL9 blood gas analyzer: A comprehensive blood gas analyzer for critical care settings. _x000D_
* Roche CoaguChek XS system: A portable coagulation monitoring system for patient self-testing.

Tandry recently showcased its latest advancements at the 86th Annual Meeting of the Taiwan Orthopedic Association (TOA), including its variable-angle locking plate system, underscoring Tandry’s commitment to innovation and quality in orthopedics. The event highlighted Tandry’s international expansion efforts and its collaboration with National Yang Ming Chiao Tung University in developing cutting-edge femoral repair technology, further establishing Tandry as a "hidden champion" of Taiwanese innovation.

Applied BioCode, multiplex diagnostics company, exhibits at 2024 Taiwan Healthcare+ Expo, showcasing comprehensive and flexible multiplex diagnostics solution, strides forward to gain global diagnostics market.

Applied BioCode’s solution has shown international traction. With premarket clearance FDA 510k and TFDA registrations for Gastrointestinal Pathogen Panel and Respiratory Pathogen Panel in hand, Applied BioCode rapidly increases install bases of its automated molecular system BioCode MDx3000 in North America recently. Based on this very system, Applied BioCode continues to develop Cov-Flu-Plus, Multiplex Fungal Panel, and STI panel plus resistance markers. Applied BioCode aims to boost presence and utility among the top 600 largest reference labs and medical centers in the US, becoming high throughput multiplex diagnostics leader, and collaborates with Taiwan’s high quality healthcare systems.

Taiwan Healthcare Plus expo will kick off on Dec. 5th in Nangang Exhibition Center I, and Applied BioCode has booth on 4th floor M403.

BriteMED's upcoming wireless 12-lead portable ECG builds upon the first generation's Windows-based portable ECG transmission, offering groundbreaking solutions for telemedicine, rural healthcare, and home care. This next-generation device features Bluetooth 5.0 technology for enhanced cross-platform compatibility, allowing real-time ECG waveform transmission on Windows, iOS, and Android devices. It also provides clinically validated diagnostic support features.
The device utilizes a non-invasive physiological signal acquisition method, making it easy to monitor patients' heart activity, and it can transmit data electronically, facilitating further tracking and diagnosis. In emergencies, it is equipped with defibrillator protection and pacemaker detection functions to ensure safe usage. BriteMED’s wireless 12-lead portable ECG effectively improves the efficiency of cardiovascular disease diagnosis and management.
Amid the rising global prevalence of cardiovascular/heart diseases, BriteMED provides practical solutions in telemedicine and smart healthcare to address current challenges in diagnosing and managing heart conditions, especially in settings like remote medical consultations, rural healthcare, home care, and mobile clinics, both inside and outside traditional hospital environments.

Dr. Linus Pauling, two-time Nobel Prize winner, once said, “The root cause of most human diseases lies in the lack of trace minerals.” This statement has had a profound impact on future generations, highlighting the importance of complete and balanced nutrition for human health. Inspired by this principle, Total Swiss is committed to providing comprehensive and balanced nutrition to promote cellular health. Following the philosophy that "when cells are healthy, people are healthy," Total Swiss actively strives to help people regain health and stay free from disease.

Since 2022, Total Swiss has partnered with DeYen Pharmaceutical, securing exclusive global sales rights for *Hepanamin Capsule*, an indicated therapy for chronic liver disease. In just one year, Total Swiss quickly expanded to over 40 *Hepanamin* pharmacies. This year, Total Swiss has further joined forces with DyterGene Technology to officially enter the field of precision medicine, becoming a health industry group that integrates precision medicine, PIC/S GMP pharmaceutical manufacturing, and nutrition and health products. Total Swiss is dedicated to offering comprehensive and superior health solutions for people both domestically and internationally.

An interdisciplinary team from the Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative artificial intelligence (AI) software system that can turn an ordinary mobile phone into a medical-grade stethoscope, allowing anyone to use a smartphone to detect heart disease symptoms at their fingertips, and subsequently seek immediate medical attention, without the need for other specialised devices. This patented AI technology enables the detection of valvular heart disease, with an estimated accuracy of 81% – a level comparable to a doctor’s assessment using a stethoscope. This invention promotes early detection of valvular heart disease, personalised health management, heart disease screening, the use of telemedicine, and remote disease monitoring.

At the forefront of future healthcare, filled with challenges, VitalSigns Corp introduces the best wireless, precise, real-time, continuous, analytical, and regulatory-compliant solution, addressing the dual challenge of improving healthcare workers' environments and enabling real-time monitoring of patients' vital signs. Through the wearable multifunctional physiological data collection device VSH101 and the physiological information gateway VSG101, we have launched the revolutionary ECG + Vitals™ service. This service provides 24-hour continuous real-time ECG monitoring and instant interpretation, even in ICU settings, bringing comprehensive monitoring to every corner, assisting dedicated healthcare workers in safeguarding every life!